logo-loader
viewFactor Therapeutics Ltd

Tissue Therapies to announce capital raising

au_australian_dollar350_51246ac3dcc8f.jpg

Tissue Therapies (ASX: TIS) has been placed into an ASX trading halt while it prepares a proposed capital raising.

The halt will last until the earlier of an announcement being made available to the market, or the opening of trade on Friday 22 February.

Tissue Therapies is currently waiting on the European Medicines Agency to complete its discussions to assign a procedural start date for the award of a CE Mark to its VitroGro® ECM treatment for hard to heal wounds.

It also plans to lodge the U.S. FDA clinical trial applications in the next few months.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Factor Therapeutics Ltd

Price: 0.003 AUD

ASX:FTT
Market: ASX
Market Cap: $3.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ioneer Ltd's Bernard Rowe hails new boric acid distribution and sales agreements

ioneer Ltd's (ASX:INR) Bernard Rowe speaks to Proactive's Andrew Scott after securing two distribution and sales agreements for the supply of boric acid from its Rhyolite Ridge Lithium-Boron Project in Nevada, USA. The three-year boric acid distribution and sales agreements were signed with...

2 days, 11 hours ago

2 min read